Drug Guide
Ketoprofen
Classification
Therapeutic: Nonsteroidal anti-inflammatory drug (NSAID)
Pharmacological: Propionic acid derivative
FDA Approved Indications
- Relief of mild to moderate pain
- Inflammation associated with rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis
Mechanism of Action
Ketoprofen inhibits cyclooxygenase (COX-1 and COX-2), leading to decreased formation of prostaglandins, thereby reducing inflammation, pain, and fever.
Dosage and Administration
Adult: Oral: 25-50 mg every 6-8 hours as needed; max dose typically 200 mg/day.
Pediatric: Not recommended for children under 16 due to safety profile.
Geriatric: Start at lower end of dosing range; monitor renal and hepatic function.
Renal Impairment: Adjust dose; use with caution due to increased risk of renal toxicity.
Hepatic Impairment: Use with caution; dose adjustment may be necessary.
Pharmacokinetics
Absorption: Well absorbed from the gastrointestinal tract.
Distribution: Widely distributed; crosses the placenta and enters breast milk.
Metabolism: Hepatically metabolized mainly via hydroxylation and conjugation.
Excretion: Primarily via the kidneys as metabolites; small amount excreted unchanged.
Half Life: Approximately 2 hours.
Contraindications
- Hypersensitivity to ketoprofen or other NSAIDs
- History of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
- Active gastrointestinal bleeding or ulceration.
Precautions
- Use with caution in patients with cardiovascular disease, hypertension, renal or hepatic impairment.
- Risk of gastrointestinal bleeding, ulceration, and perforation.
Adverse Reactions - Common
- Gastrointestinal upset (nausea, dyspepsia) (Common)
- Dizziness, headache (Common)
Adverse Reactions - Serious
- Gastrointestinal bleeding or ulceration (Less common)
- Cardiovascular thrombotic events (myocardial infarction, stroke) (Less common)
- Allergic reactions (anaphylaxis, skin reactions) (Uncommon)
Drug-Drug Interactions
- Warfarin, other anticoagulants
- Other NSAIDs, corticosteroids—risk of bleeding
- ACE inhibitors and diuretics—reduced efficacy and renal risks
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor for signs of bleeding, gastrointestinal disturbances, and renal function.
Diagnoses:
- Risk for bleeding
- Impaired kidney function
- Gastrointestinal discomfort
Implementation: Administer with food or milk to decrease gastrointestinal irritation; monitor renal function periodically.
Evaluation: Assess pain relief, reduction in inflammation, and side effects.
Patient/Family Teaching
- Take with food or milk to minimize GI upset.
- Report unusual bleeding, stomach pain, or signs of allergic reaction.
- Do not exceed recommended dose.
- Avoid alcohol and smoking.
Special Considerations
Black Box Warnings:
- Serious cardiovascular thrombotic events, including myocardial infarction and stroke, have been reported with NSAID use.
- Gastrointestinal bleeding, ulceration, and perforation risk.
Genetic Factors: None specified.
Lab Test Interference: May increase bleeding times, affect renal function tests.
Overdose Management
Signs/Symptoms: Nausea, vomiting, epigastric pain, dizziness, and somnolence; severe cases may involve gastrointestinal bleeding or renal impairment.
Treatment: Supportive care, activated charcoal if early, monitor renal function, and treat symptoms. Hemodialysis is not typically effective.
Storage and Handling
Storage: Store at room temperature, 20-25°C (68-77°F).
Stability: Stable under recommended conditions for shelf life.